The Chief Executive Officer (CEO) of Enlaza Therapeutics is Dr. Sergio Duron.
Leadership at Enlaza Therapeutics
Dr. Sergio Duron holds the position of CEO at Enlaza Therapeutics, a biotechnology firm dedicated to pioneering innovative therapeutic solutions. Under his guidance, the company is developing an advanced covalent biologic therapeutic platform. This platform is designed to integrate recent scientific advancements, allowing for the introduction of proprietary unnatural amino acids into protein drugs. This enables these drugs to achieve specific covalent binding with their target proteins, representing a significant step forward in drug development.
Enlaza Therapeutics initiated its operations with substantial financial backing, specifically aimed at advancing this platform and bringing forward new biologic therapies with enhanced binding capabilities.
